We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Effect of somatostatin on blood sugar, plasma growth hormone, and glucagon levels in diabetic children.
- Authors
Del Guercio, M. J.; di Natale, B.; Gargantini, L.; Garlaschi, C.; Chiumello, G.
- Abstract
In nine children with clinically overt insulin-dependent diabetes mellitus the authors injected cyclic somatostatin (3 mug./kg. bolus, followed by infusion of 13 mug./kg. in 60 minutes) and measured blood glucose, plasma growth hormone, and glucagon concentrations throughout the infusion. The rapid administration produced no significant changes of these parameters. With the prolonged infusion there was a significant reduction of blood glucose from a mean of 148 +/- 19.7 to a mean of 88.5 +/- 18.1 mg./100 ml. (P less than 0.005) and of plasma glucagon from a basal mean of 33.3 +/- 2.4 to a minimum mean of 22.1 +/- 1.7 pg./ml. (P less than 0.01). There was a statistically significant correlation between the two parameters (0.01 less than P less than 0.05). Plasma GH values also diminished during the infusion, but the reduction was not statistically significant. These results show that somatostatin lowers blood glucose concentrations as a secondary effect of inhibition of glucagon secretion. Somatostatin is not suitable for therapy in diabetes. We speculate that a similar substance with a more prolonged and specific action on glucagon might prove of practical value in the treatment of diabetes mellitus.
- Publication
Diabetes, 1976, Vol 25, Issue 7, p550
- ISSN
0012-1797
- Publication type
journal article
- DOI
10.2337/diabetes.25.7.550